ColonSentry® is a proprietary liquid biopsy test that uses advanced gene expression (mRNA) technology for the early identification of Colorectal Cancer (CRC). If the ColonSentry score is elevated in a patient at average risk, there is an increased probability the patient may have a pre-cancerous lesion or colorectal cancer.
Patients may candidate for the ColonSentry Test if they are
- Age 45 of older and at average risk for Colorectal Cancer
- Are without symptoms such as bleeding, abdominal pain, or change in bowel habits.
- Have not had a Colonoscopy or Stool-Based Screening Test
After we receive your order, a client relations specialist will be in touch to walk you through the simple and easy process to getting your test performed.